Jack Ball

Jack T.
Ball currently works at Carterra, Inc., as Director, SwitchGear Genomics, Inc., as Director, RealBio Technology, Inc., as Director, ViroCyt, Inc., as Director from 2013, KromaTid, Inc., as Director, Cytek Biosciences, Inc., as Lead Independent Director, and Tyball Associates, Inc., as President.
Mr. Ball also formerly worked at Amnis Corp., as Chief Executive Officer, Solulink, Inc., as Chief Executive Officer & Director from 2013 to 2019, Aquaro Histology, Inc., as Executive Chairman, Celsee LLC, as Director, Essen Instruments, Inc., as Director, 3D Biomatrix, Inc., as Director, Swift Biosciences, Inc., as Director from 2010 to 2021, PHASIQ, Inc., as Director, NanoCellect Biomedical, Inc., as Director from 2021 to 2023, Orchid Cellmark, Inc., as Senior VP & General Manager-Life Sciences Group, Amersham Pharmacia Biotech, Inc., as President-North America Sales from 2012 to 2013, Accuri Cytometers, Inc., as Chief Commercial Officer from 2006 to 2011, Molecular Probes, Inc., as Chief Commercial Officer, and GE Healthcare Bio-Sciences, Inc., as Principal.
Mr. Ball received his undergraduate degree from the University of Georgia.